You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (1) |
Back to Search
Is Japan about to switch on medicines reclassification?
- In: Posters
- At: Amsterdam (the Netherlands) (2012)
- Type: Poster
- Poster code: SAPS-P-14
- By: GAULD, Natalie (University of Auckland, General Practice and Primary Healthcare, Auckland, New Zealand)
- Co-author(s): Kurosawa, N. (Hokkaido Pharmaceutical University, Sapporo, Japan)
Kelly, F. (University of Auckland, Auckland, New Zealand)
Emmerton, L. (Curtin University, Perth, Australia)
Buetow, S. (University of Auckland, Auckland, New Zealand) - Abstract:
Background: Prescription to non-prescription reclassification (‘switch’) might help to relieve pressure on health funding from Japan’s aging population. Reclassification has been proposed for medicines including ACE inhibitors and diabetes agents.Aims: To ascertain barriers and enablers for medicines reclassification in Japan.Methods:
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026